Kentucky Trust Co Purchases Shares of 15,512 CVS Health Co. (NYSE:CVS)

Kentucky Trust Co bought a new stake in shares of CVS Health Co. (NYSE:CVS) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,512 shares of the pharmacy operator’s stock, valued at approximately $696,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. MidAtlantic Capital Management Inc. acquired a new position in CVS Health during the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC raised its stake in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health in the fourth quarter worth approximately $28,000. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health in the third quarter worth approximately $31,000. Finally, Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health in the third quarter worth approximately $31,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 1.3 %

NYSE CVS opened at $55.01 on Wednesday. The stock’s 50-day simple moving average is $50.69 and its two-hundred day simple moving average is $55.95. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $69.23 billion, a price-to-earnings ratio of 13.96, a PEG ratio of 0.60 and a beta of 0.61.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.84%. CVS Health’s payout ratio is 67.51%.

Analyst Ratings Changes

A number of analysts recently commented on CVS shares. Truist Financial decreased their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada decreased their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. TD Cowen increased their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Evercore ISI increased their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $67.78.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.